MapLight Therapeutics, Inc. — Form S-1/A
Filed September 18, 2026 · analyzed by the Registration Agent
S-1/A
— Neutral
significance 12/100
What the filing says
MapLight Therapeutics filed Amendment No. 1 to its Form S-1 on September 18, 2026, solely to correct the number of shares outstanding as of September 1, 2026. No new securities are being registered. The amendment relates to a private placement that closed August 14, 2026, in which MapLight issued 9,197,887 common shares and pre-funded warrants to purchase 3,983,168 shares at $11.38 per share, raising ~$150M gross. The company received $150.0 million in gross proceeds before placement agent fees. Up to 13,181,055 shares (including warrant shares) are now registered for resale by selling stockholders.
Why this rating
Administrative amendment correcting a technical error (share count) with no economic impact. Company does not receive proceeds from resales. Immaterial relative to $368M asset base.
Extracted items
- 2.02 results / earnings
- 7.01 Reg FD disclosure
See more from September 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.